Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: JJMM who wrote (3356)	5/22/1998 10:30:00 AM
From: Leman	Respond to of 25711

To: brasilbound (98 ) From: Leman Friday, May 22 1998 10:26AM ET Reply # of 99 check out HYALF patents 5674857 Use of hyaluronic acid to repair ischemia reperfusion damage 80% 5639738 Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs 80% 5614506 Use of hyaluronic acid and forms to prevent arterial restenosis 80% 5079236 Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use 80% 5077296 Method for treating equine navicular disease with pentoxifylline, and composition containing pentoxifylline for administrating to horses 80% 5039521 Immune cell proliferation inhibitors